Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

EEG-acp

K-Number: K212325 · 2022-06-15

Decision Date2022-06-15
Product CodeGYB
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

EEG-acp is a medical device manufactured by Somnomedics GmbH. It received FDA 510(k) clearance on 2022-06-15 under approval number K212325. The device is classified under product code GYB. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the EEG-acp?

EEG-acp is a medical device that received FDA 510(k) clearance on 2022-06-15. It is manufactured by Somnomedics GmbH. The 510(k) number is K212325.

When was EEG-acp approved by the FDA?

EEG-acp received FDA 510(k) clearance on 2022-06-15, under approval number K212325.

What company makes EEG-acp?

EEG-acp is manufactured by Somnomedics GmbH.

What is the FDA product code for EEG-acp?

The FDA product code for EEG-acp is GYB.

Other Devices by Somnomedics GmbH

Related Devices (Code: GYB)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.